Physician profile
Dean Adams
NPI 1700926078
$12,094.59
in general payments reported to CMS, 2019-2025
25 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,392 · 2020: $82.41 · 2021: $2,447 · 2022: $620 · 2023: $177 · 2024: $221 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,239.02 | 2019-2025 | |
| Cumberland Pharmaceuticals, INC. | $4,591.66 | 2019-2021 | |
| Medtronic USA, INC. | $850.68 | 2019 | |
| Thd America, INC. | $326.97 | 2020-2021 | |
| Organogenesis INC. | $149.21 | 2022-2024 | Puraply |
| Takeda Pharmaceuticals U.S.A., INC. | $137.41 | 2020-2025 | Gattex |
| Medtronic, INC. | $99.43 | 2022-2025 | Interstim, Ligasure |
| Smith+Nephew, INC. | $98.99 | 2019-2024 | Collagenase Santyl, Grafix Pl, Stravix Pl |
| Celgene Corporation | $78.85 | 2022-2024 | Zeposia |
| Conmed Corporation | $72.69 | 2021-2023 | Airseal |
| Janssen Pharmaceuticals, INC | $61.09 | 2021-2022 | |
| Endologix LLC | $55.25 | 2025 | Endocross Device, Torus Stent Graft System |
| Braintree Laboratories, INC. | $47.93 | 2019-2025 | Sutab |
| Baxter Healthcare | $39.32 | 2019-2021 | |
| Roche Diagnostics Corporation | $36.78 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.77 | 2022-2025 | Axonics |
| Ambu INC. | $31.65 | 2023 | |
| Olympus America INC. | $21.38 | 2023 | 4k Camera Head, Olympus, 4k Cable 8.5m |
| Amgen INC. | $20.19 | 2020 | |
| Axonics, INC. | $20.08 | 2022 | |
| Ethicon US, LLC | $19.41 | 2021 | |
| Myriad Genetic Laboratories, INC. | $17.48 | 2022 | |
| Merck Sharp & Dohme LLC | $17.27 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.80 | 2024 | Exparel |
| Lemaitre Vascular, INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.